Pacific Biosciences of California, Inc. (PACB): Shareholders' Equity
$5.35M
As of 2025-12-31
-$33.21M
As of 2026-06-30
-78.8%
3-year compound annual growth
-56.3%
5-year compound annual growth
-23.1%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.35M | -98.9% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $506.59M | -27.8% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $701.30M | +24.6% | 2026-02-25, Balance as of period end |
| 2022-12-31 | $562.90M | -28.8% | 2025-03-17, Balance as of period end |
| 2021-12-31 | $790.99M | +135.8% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $335.49M | +510.9% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $54.92M | -51.9% | 2022-02-28, Balance as of period end |
| 2018-12-31 | $114.06M | +32.5% | 2021-02-26, Balance as of period end |
| 2017-12-31 | $86.10M | +1.7% | 2020-02-28, Balance as of period end |
| 2016-12-31 | $84.67M | +15.1% | 2019-02-26, Balance as of period end |
| 2015-12-31 | $73.54M | +33.8% | 2018-02-26, Balance as of period end |
| 2014-12-31 | $54.95M | -20.6% | 2017-03-06, Balance as of period end |
| 2013-12-31 | $69.18M | -36.8% | 2016-03-11, Balance as of period end |
| 2012-12-31 | $109.38M | -42.9% | 2015-03-12, Balance as of period end |
| 2011-12-31 | $191.46M | -31.6% | 2014-03-14, Balance as of period end |
| 2010-12-31 | $279.87M | n/m | 2013-03-15, Balance as of period end |
| 2009-12-31 | -$177.12M | n/a | 2012-03-01, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $5.35M | -98.9% |
| Quanterix Corp (QTRX) | 2025-12-31 | $295.73M | -10.4% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $341.74M | -13.6% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $13.73M | -78.3% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $143.70M | +25.4% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $796.33M | +12.1% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $33.21M | -55.9% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $306.11M | -9.0% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $44.42M | +25.6% |
Compare PACB, QTRX, CTKB, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗